LUGPA Announces 2017 Board of Directors

( – LUGPA, the trade association that advocates for independent urology group practices today announced its 2017 LUGPA Board of Directors. 

The newly elected 2017 Officers are: Neal D. Shore, MD, Myrtle Beach, S.C., President; Richard G. Harris, MD, Melrose Park, Ill., President-Elect; and Jonathan Henderson, MD, Shreveport, La., Secretary.

  • Neal D. Shore, MD is the medical director or the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. He has conducted more than 250 clinical trials focusing mainly on GU Oncology, and has served as a founding LUGPA Board member since 2009. 

  • Richard G. Harris is founding member and CEO of UroPartners, an integrated urology/oncology/radiation oncology practice with more than sixty physicians. He has served on the LUGPA Board since 2010. 

  • Jonathan Henderson has more than 25 years of diverse experience in urology and currently practices with Regional Urologists, LLC., Shreveport, Louisiana, and has served on the LUGPA Board since 2011.

Newly elected as a member to the 2017 LUGPA Board of Directors is: Michael D. Fabrizio, MD, Virginia Beach, Va.  Dr. Fabrizio is the Chief Executive Officer of The Virginia Practice, Virginia Beach, Va.

Continuing 2017 LUGPA Board members are: Treasurer, Robert D. Asinof, MSHA, Denver, Colo; David M. Carpenter, Woodbury, Minn., David C. Chaikin, MD, Morristown, NJ; Evan R. Goldfischer, MD, MBA, CPI, Poughkeepsie, New York; Kathy Hille, Ph.D., Houston, Texas; Alec S. Koo, MD, Torrance, California; Bryan A. Mehlhaff, MD, Springfield, Oregon; Scott B. Sellinger, MD, Tallahassee, Fla.; and Gary Kirsh, Past President.

The LUGPA Board will continue its dedication toward fulfilling its Mission to provide urological surgeons practicing within the context of integrated group practices the means to access resources, technology and management tools that will enable them to furnish all services needed to care for patients with acute and chronic illnesses of the genitourinary system in an efficient, cost-effective and clinically superior manner, while using data collection to create parameters that demonstrate quality and value to patients, vendors, third party payors, legislators, and regulatory agencies. In addition, we are committed to expanding our organizations’ outreach and membership involvement.

“LUGPA’s  2017 Board of Directors is well positioned to continue to advance independent urology practices by advancing value-based medicine by preserving and protecting the independent, integrated model of urological care,” said, Celeste Kirschner, LUGPA, Chief Executive Officer.

LUGPA has currently grown to represent more than 25 percent of the nation’s urology practices, comprising more than 2,100 members, whom account for approximately 30 percent of urologic care in the United States. The Association is committed to providing the best resources and information for its member practices through advocacy, research, data collection and benchmarking efforts. LUGPA advocates for independent urology practices by promoting quality clinical outcomes, fostering new opportunities and improving advocacy in the legislative and regulatory arenas.